GOVERNMENT BUSINESS

Kraken Awarded Robotics as a Service (RaaS) Contract from Government of Canada

Kraken Robotics Inc. | October 25, 2021

Kraken Awarded Robotics as a Service (RaaS) Contract from Government of Canada
Kraken Robotics Inc. , Canada’s Ocean Company™, is pleased to announce that it has signed a Robotics as a Service (RaaS) contract with the Canadian government for testing of Kraken’s ultra-high resolution survey equipment with the Royal Canadian Navy (RCN). This $0.5 million contract is funded under the Canadian government’s Innovative Solutions Canada program, and the testing department for this service offering is the RCN’s Fleet Diving Unit Atlantic (FDU-A) based in Halifax, Nova Scotia. The RCN has a mandate to develop and maintain an advanced sonar imaging and data storage capability for all three coasts, and to deploy this capability to national and international areas of interest. Under the contract, Kraken will deploy its KATFISH™ towed SAS sonar system and will integrate a Kraken Light Weight SAS (LW-SAS) onboard a Hydroid REMUS 100 Autonomous Underwater Vehicle (AUV) owned by FDU-A. This contract will be completed by March 31, 2022.

Augmenting the RCN’s Current Capabilities

This contract will provide the RCN FDU-A access to cutting edge technology and high-resolution seabed data. FDU-A uses a number of different seabed imaging sonar solutions for their various mission requirements, including Towed Sonars Systems (typically deployed from a Kingston-class MCDV vessel, with a crew of 40 persons), and Light Weight Sonar Systems (typically deployed from REMUS-class AUVs). Kraken’s RaaS service can augment FDU-A’s existing capabilities, by providing them with significantly better data, at a much lower cost, and leveraging continuously improving capabilities.

The contract involves testing the Kraken RaaS capability in two configurations:

  1. Towed KATFISH™ Synthetic Aperture Sonar (SAS) system, deployed on a Surface Vessel of Opportunity (the R/V Ocean Seeker). This could also be tested onboard an RCN Asset (such as the Kingston-class MCDV). One purpose of the test is to show that in combination with RaaS, vessels of opportunity can also be used at a lower cost and higher availability to augment the RCN's capabilities.
  2. Untethered Light Weight SAS system, deployed on an RCN Underwater Vessel of Opportunity (REMUS 100 AUV), and tested with the KATFISH™ system above. A purpose of this test is to show that RaaS can be quickly added to existing RCN assets, to augment their capabilities.

Benefits to the Navies

Kraken believes its RaaS offering could provide significant benefits to other navies around the world. With Kraken RaaS, navies can access cutting edge technology “as needed”, without concern for equipment obsolescence, life cycle costs, or operator skill fade. As it relates specifically to the RCN, Kraken RaaS offers many advantages:

  • Both RCN operating bases, MARLANT (Maritime Forces Atlantic) and MARPAC (Maritime Forces Pacific) are mandated to maintain Q-routes (safe passage lanes along the coasts and into designated harbors, of Canadian waters) on an annual basis. These surveys take a significant amount of time with current RCN technology due to image quality and speed of current towed bodies. Kraken’s technology would greatly enhance the image quality and reduce the time of the surveys significantly due to the advance in state-of-the-art technology.
  • Kraken’s technology can be deployed to assist the RCN in mapping areas of interest ahead of regular exercises and operations, with the image quality required to enable change detection and optimize revisit rates. This has the potential to provide the RCN with a competitive edge for detecting bottom objects in complex seabeds.
  • Kraken’s technology and service application can augment route survey activities while simultaneously supporting near shore hydrographic mapping and charting requirements on an annual basis with high-definition resolution, freeing up valuable Navy assets for other mission critical functions

CEO Comments
Commenting on this contract, Karl Kenny, Kraken President and CEO noted, “Kraken is excited to be able to offer RaaS to the RCN as an “Early Adopter” to augment existing RCN Route Survey with a Service offering based on the latest SAS technology available. Kraken seeks to offer our Robotics as a Service globally, in particular to other NATO allies, and this contract for the RCN’s evaluation will serve as an excellent reference. The RCN’s objective comparison of the data from our RaaS offering against legacy sonar data will provide demonstrative evidence of the superior image resolution and accuracy of Kraken survey data.”

ABOUT KRAKEN ROBOTICS INC.
Kraken Robotics Inc. (TSX.V:PNG) (OTCQB: KRKNF) is a marine technology company dedicated to the production and sale of software-centric sensors, subsea batteries and thrusters, and underwater robotic systems. The company is headquartered in Newfoundland with offices in Canada, U.S., Germany, Denmark, and Brazil. In July 2021, Kraken acquired PanGeo Subsea, a leading services company specializing in high-resolution 3D acoustic imaging solutions for the sub-seabed. PanGeo with offices in Canada, the United States and the United Kingdom is now a wholly owned subsidiary of Kraken. Kraken is ranked as a Top 100 marine technology company by Marine Technology Reporter.

Spotlight

As Donald Trump reiterated his determination that Americans should walk on Mars, Mike Pence marked the 50th anniversary of the first moon landing at the Apollo 11 launch site in Florida on Saturday.


Other News
GOVERNMENT FINANCE

Xlear Files Legal Response to Government’s Lawsuit

Xlear | December 23, 2021

Today, Xlear Inc. filed the company’s response to a Department of Justice lawsuit alleging violations of the Federal Trade Commission Act, among other allegations. The company denied all the Government’s allegations and leveled a series of affirmative defenses at the Government, including violations of Xlear’s First Amendment right to free speech. Nathan Jones, Xlear’s CEO, issued this statement regarding Xlear’s Response: The United States faces an already raging pandemic and yet another new, wildfire Omicron variant, which studies show is more transmissible, vaccine resistant and as severe as other strains. As a result, across the nation new cases are spiking and breaking records; hospitals are once again overflowing; schools are closing again; not only are we seeing breakthrough infections—we are facing reinfections; the NFL and the NHL have been forced to postpone games; and, there is a real risk that our lives and economy will once again have to close. It’s another COVID-Christmas in America. The nation’s vaccine-only strategy is failing. Despite this, the Federal Government continues to refuse to even discuss or consider other possible countermeasures—even though they are backed by sound science. Xlear’s Response outlines a series of studies, including two randomized clinical trials (RCTs)* and other clinical and lab data, that more than substantiate Xlear’s statements regarding COVID-19. One recent RCT study found that the use of nasal hygiene in treating COVID-19-infected people over the age of 50 reduced the risk of hospitalization 8-fold.** The Government hasn’t meaningfully challenged the legitimacy of these studies—the Government can’t, they paid for some of them and have published some of them. Nor has the Government offered conflicting studies—they can’t. The Government has known about these other countermeasures since June 2020. Yet, the Government still refuses to even discuss or consider them. The Response we filed also includes a new in vitro study done at Utah State University’s Institute for Antiviral Research.*** This new in vitro study (using human airway tissue) found that the components in Xlear were significantly more effective antivirals against the Delta strain of COVID-19 than Remdesivir, the Government-approved antiviral medicine. Ironically, the Government alleges it is Xlear that has misled the public. Not only is the Government refusing to consider other countermeasures, the Government, through this lawsuit, has sought to censor us from informing the American people about the science. The American people have both the right and the need to know the science. We hope this lawsuit serves as a vehicle to inform the public, as well as expose the abject failures of our Government in responding to this pandemic.

Read More

GOVERNMENT BUSINESS

HawkEye 360 Awarded $15.5 Million Contract with Air Force Research Laboratory

HawkEye 360 | January 11, 2022

HawkEye 360 Inc., the world's leading commercial provider of space-based radio frequency (RF) data and analytics, today announced it has been awarded a three year, $15.5 million Experimental Purpose Agreement (EPA) contract with the Air Force Research Laboratory's (AFRL) Space Vehicles Directorate. Through the agreement, HawkEye 360 will provide radio frequency analytics research, development, and experiments to help the government demonstrate, test and evaluate its hybrid space ISR architecture. "This agreement is a tremendous opportunity for HawkEye 360 to showcase the whole spectrum of capability we offer the government as it develops its space architectures," said CEO John Serafini. "We deliver value not only through the efficient tasking, collection and delivery of our RF data, which has never before been commercially available, but also through embedded operational support and enhanced analytics capabilities, deriving applicable insights for diverse end users. Ultimately, we hope to shape a pathway for further integration of valuable commercial capabilities into the government's space architecture." HawkEye 360 has previously supported numerous Air Force Research Laboratory exercises, but had never done so through a direct contract vehicle. As part of the new agreement, HawkEye 360 will support a variety of operational use cases by providing embedded personnel support, data collection, tools for data ingestion, analytics and more. The agreement scope includes participating military exercises, such as the Rim of the Pacific Exercises, to introduce new capabilities to the warfighter and identify ways to improve and integrate into operational workflows. The EPA contract vehicle is available for use by all Combatant Commands as they look to test and demonstrate innovative commercial RF data and analytics to include Direct Downlink to government ground stations. "We appreciate the opportunity to partner with one of the most prestigious military research organizations in the world," said Alex Fox, Executive Vice President for Global Growth. "Our team is excited to be part of an AFRL program focused on developing and transitioning space capabilities for more effective and affordable warfighter missions. We share AFRL's vision for a hybrid government and commercial ISR architecture to address growing global threats and to provide the warfighter with high-impact insights needed to support their mission." "The Department of Defense constantly seeks to identify, evaluate and recommend commercial intelligence, surveillance, and reconnaissance capabilities for integration into United States Air Force and United States Space Force workflows," said AFRL Technical Program Manager Charlene Jacka. "We are pleased to have the opportunity to explore at greater scale and depth, using real-world scenarios, how a leading radio frequency data and analytics provider such as HawkEye 360 can supplement and strengthen our hybrid satellite ISR architecture, and to develop new tactics, techniques and procedures to enable further utility assessments." HawkEye 360 operates a growing constellation of satellites which detects, characterizes and precisely geolocates radio frequency signals from a broad range of emitters used for communication, navigation and security. By processing and analyzing this RF data, the company delivers high-impact actionable insights across a broad range of sectors, including environmental protection and national security. About Hawkeye 360 HawkEye 360 is a Radio Frequency (RF) data analytics company. We operate a first-of-its-kind commercial satellite constellation to identify, characterize, and geolocate a broad set of RF signals. We extract value from this unique data through proprietary algorithms, fusing it with other sources to create powerful analytical products that solve hard challenges for our global customers. Our products include maritime domain awareness and spectrum mapping and monitoring; our customers include a wide range of commercial, government and international entities.

Read More

GOVERNMENT BUSINESS

Valneva and Scottish Enterprise in Advanced Discussions for Major Grant to Complete Livingston Site

Valneva | December 24, 2021

Valneva SE , a specialty vaccine company, today announced that it is in advanced discussions, with Scottish Enterprise, for a multi-million pound grant which will enable it to fully complete its strategic manufacturing site in Livingston, Scotland. Following the termination of the supply agreement with the UK Government (HMG) for Valneva’s inactivated COVID-19 vaccine candidate, VLA2001, Valneva paused its site plans. Valneva and Scottish Enterprise have since engaged in a highly constructive dialogue, and under the proposed grant, the Livingston site will be fully developed as a key vaccine production site for the long term. Both Valneva and Scottish Enterprise would invest in the plant. Scottish Enterprise’s contribution is expected to be through a series of grants totalling £10-20 million to enable Valneva to commence production at the plant. Discussions between the Company and the Scottish Government also include potential supply of VLA2001 for Scotland in the future, subject to regulatory approval. Valneva has also offered to make up to 25,000 doses of VLA2001 available for primary immunisation, free of charge, to National Health Service and frontline workers in Scotland, subject to regulatory approval. The grant is subject to contract and final due diligence and is expected to include commitments to jobs for the future in Livingston. Commenting, David Lawrence, Acting Chief Financial Officer, said “We’re pleased that we’ve been able to advance discussions with Scottish Enterprise quickly, following the UK Government’s unexpected decision to terminate our supply agreement with them. We’ve reported excellent Phase 3 data and homologous booster data in the past couple of months, underlining the potential importance of VLA2001 – our inactivated, adjuvanted whole virus vaccine. Subject to regulatory approval we want to make VLA2001 available to people who need it, as soon as we can. We already have some vaccine stock available for distribution, upon approval. The grant will be very welcome and, subject to contract, will ensure that Livingston becomes a strategic vaccine manufacturing site for the future, successfully completing the work we began with HMG”. Ivan McKee, Scottish Government Minister for Business, Trade, Tourism and Enterprise, said “Valneva is a valued contributor to our life sciences sector and the Livingston facility is an important asset, developing vaccines for the treatment of several important infectious diseases and supporting high quality jobs. Ministers and Scottish Enterprise are in advanced discussions with the company to agree a package of support which would underpin the company’s operations in Scotland.” Hannah Bardell, MP for Livingston, added “I am delighted that the Scottish Government and Scottish Enterprise have listened to my constituency colleagues and I by agreeing to invest in Valneva’s vaccine manufacturing site in Livingston. This funding will enable Valneva to complete its expansion, boosting vital production capacity and protecting skilled jobs. It has been a pleasure to work with all involved in securing this agreement and I can only hope the UK Government will see the faith that we in Scotland have in Valneva.” Valneva is continuing to try to reach an amicable resolution with HMG regarding its termination of the supply agreement and performance of the ongoing clinical trial agreement. The Company continues to reserve all rights in the event that an amicable outcome is not achieved. About VLA2001 VLA2001 is currently the only whole virus, inactivated, adjuvanted vaccine candidate against COVID-19 in clinical trials in Europe. It is intended for active immunization of at-risk populations to prevent carriage and symptomatic infection with COVID-19 during the ongoing pandemic and potentially later for routine vaccination including addressing new variants. VLA2001 may also be suited for boosting, as repeat booster vaccinations have been shown to work well with whole virus inactivated vaccines. VLA2001 is produced on Valneva’s established Vero-cell platform, leveraging the manufacturing technology for Valneva’s licensed Japanese encephalitis vaccine, IXIARO®. VLA2001 consists of inactivated whole virus particles of SARS-CoV-2 with high S-protein density, in combination with two adjuvants, alum and CpG 1018. This adjuvant combination has consistently induced higher antibody levels in preclinical experiments than alum-only formulations and shown a shift of the immune response towards Th1. CpG 1018 adjuvant, supplied by Dynavax Technologies Corporation (Nasdaq: DVAX), is a component of the US FDA- and EMA-approved HEPLISAV-B® vaccine. About Valneva SE Valneva is a specialty vaccine company focused on the development and commercialization of prophylactic vaccines for infectious diseases with significant unmet medical need. The Company takes a highly specialized and targeted approach to vaccine development and then applies its deep understanding of vaccine science to develop prophylactic vaccines addressing these diseases. Valneva has leveraged its expertise and capabilities both to successfully commercialize two vaccines and to rapidly advance a broad range of vaccine candidates into and through the clinic, including candidates against Lyme disease, the chikungunya virus and COVID-19.

Read More

GOVERNMENT BUSINESS

GovOS Acquires Advanced Workflow Technology from Seliom

GovOS | January 14, 2022

GovOS, a leading provider of digital transformation solutions for local governments, announced today it has acquired Seliom's advanced business process automation and workflow platform in an asset purchase transaction. Seliom technology will be integrated into the suite of GovOS solutions so that local governments can use the highly customizable workflow processing functionality to enhance their digital capabilities and make life easier for employees and citizens. Seliom technology adds to the growing GovOS digital transformation platform with its elegant and detailed workflow automation capabilities. By replacing human-based workflows and rote decision-making, the product will effectively free government staff from routine, time-consuming tasks in lieu of tackling the more complex processes and decisions that require a human touch. "The ever-evolving landscape of local government requires the public sector to be more effective and more efficient in providing services to constituents," said Kevin Lafeber, President, GovOS. "As such, we continually evaluate opportunities that make GovOS solutions more useful for our customers. Seliom's next-gen workflow platform was an obvious product fit that will immediately benefit agencies using GovOS technology to accelerate digital transformation and effect real change in their communities." This new workflow functionality provides GovOS solutions with integrations to most popular ERP, CRM and HR systems, making it possible to maintain data continuity without replacing entire systems. The technology also enables validation of data/actions against a third-party data source, a next level solution integration requiring much less reliance on monolithic solutions. "We liked that Seliom was specifically engineered to streamline standardized and dispersed operations that consume time better spent elsewhere," said Chachi Camejo, Senior Vice President of Product, GovOS. "With these capabilities fully integrated, government staff can further automate processes to get more done with the same resources." GovOS workflow technology will become an integral part of the GovOS digital transformation platform, including Business Licensing, Online Civic Services, STR (Short-Term Rentals), Tax Filing, Records, Remote Applications, and much more. About GovOS GovOS is the leading digital transformation platform for local governments. Headquartered in Austin, TX, GovOS serves government agencies of all sizes across the United States. Through its secure and integrated suite of cloud-based solutions, governments can automate and streamline operations, provide seamless access to resources and information, and deliver cutting-edge digital services to businesses, residents and agencies.

Read More